Dyadic International (NASDAQ:DYAI) Share Price Passes Below Fifty Day Moving Average of $1.36

Dyadic International, Inc. (NASDAQ:DYAI)’s stock price passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $1.36 and traded as low as $1.22. Dyadic International shares last traded at $1.23, with a volume of 7,944 shares changing hands.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reissued a “buy” rating and set a $6.00 price target on shares of Dyadic International in a research report on Monday, July 8th.

Dyadic International Stock Down 0.8 %

The stock has a market cap of $35.96 million, a PE ratio of -4.39 and a beta of 0.74. The company has a debt-to-equity ratio of 1.72, a current ratio of 5.39 and a quick ratio of 5.39. The company has a 50 day moving average price of $1.36 and a two-hundred day moving average price of $1.57.

Dyadic International (NASDAQ:DYAI) last posted its earnings results on Tuesday, August 13th. The biotechnology company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($0.01). Dyadic International had a negative net margin of 428.86% and a negative return on equity of 145.95%. The company had revenue of $0.39 million for the quarter, compared to the consensus estimate of $1.00 million. During the same quarter in the prior year, the company posted ($0.07) EPS. Analysts expect that Dyadic International, Inc. will post -0.26 EPS for the current year.

Institutional Investors Weigh In On Dyadic International

A hedge fund recently raised its stake in Dyadic International stock. Chapin Davis Inc. grew its holdings in shares of Dyadic International, Inc. (NASDAQ:DYAI) by 2.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 847,301 shares of the biotechnology company’s stock after acquiring an additional 21,000 shares during the period. Chapin Davis Inc. owned about 2.90% of Dyadic International worth $1,254,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 27.95% of the stock is owned by hedge funds and other institutional investors.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.